Jun 18, 2024
Spotlight on Foundation Grants: Using AI to Assess Cataract Surgery Performance
The Doctors Company Foundation highlights a project to develop an AI system for assessing surgical competency in cataract surgery.
From
The Doctor’s Advocate
Search
The Doctors Company Assists Members Impacted by Hurricane Ian
Due to potential disruption to member medical practices from Hurricane Ian, The Doctors Company will adjust policy cancellation and premium installment due dates for its Florida members.
Mar 04, 2024
Patient Safety Impact Story: Documentation Can Prevent Litigation
Our experts partnered with a general surgery practice to dramatically improve its after-hours call documentation rate.
From
The Doctor’s Advocate
Strategies for Effective Patient-Assisted Telehealth Assessments
Physicians who practice telemedicine must consider the components needed to complete an effective remote assessment and plan ahead based on their specialty area and the patient’s presenting complaint.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Insurance Applicant Business Associate Agreement
This Business Associate Agreement is entered into by and between The Doctors Company, an Interinsurance Exchange, including all of its subsidiaries.
The Doctors Company Recognized for Providing Expert Insights and Resources in Changing Healthcare Landscape
The Insurance Marketing and Communications Association (IMCA) recognized The Doctors Company for its exceptional efforts to educate and support healthcare professionals as they navigate the rapidly changing healthcare industry, especially as they adapt to evolving technologies.
February 28, 2023, Medtech Insight
So the Public Health Emergency Is Over. Now What?
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, provides insight about what the official end of the COVID-19 emergency means for average Americans.
October 05, 2022, Business Insurance
Dobbs Decision Casts Shadow on Med Mal
Robert White, President of The Doctors Company and TDC Group, explains how the U.S. Supreme Court decision to overturn the 50-year-old Roe vs. Wade ruling has created uncertainty for medical providers and medical malpractice insurers.
February 12, 2023, Medical Device & Technology
Urgency Needed for Medical Grade Wearables
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, discusses the importance of understanding how technology like wearables impacts medical liability.
